Sesh is developing the next generation of cancer diagnostics. Our company specializes in predictive biomarkers and non-invasive approaches that:
1) Optimize treatment selection for patients
2) Introduce new indications for immunotherapy combinations and monotherapies
3) Add to the repertoire of patient-specific biomarker information diagnostic companies offer in their assay reports
Sesh's innovative approach to technology development prioritizes cancer care improvement and employee satisfaction, quality of life, and personal growth.
Company Details
- Employees
- 2
- Founded
- 2024
- Address
- Of Technology Transfer. Xiaonao Was Joined By Industry Leaders
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.oncologysesh.com
- Keywords
- Reston.
Sesh Incorporated Questions
Sesh Incorporated's website is http://www.oncologysesh.com
Sesh Incorporated's LinkedIn profile is https://www.linkedin.com/company/sesh-incorporated
Sesh Incorporated has
2 employees.
View email and phone details for 2
employees at Sesh Incorporated.
Sesh Incorporated's industry is
Biotechnology Research
Sesh Incorporated's top competitors are
Advantage Green, Inc.,
Africa Life Sciences Network,
Hasi Movement,
Nci Technology Transfer Center,
Theravac Biotech,
Cmc Positions, Inc.,
Mobius Therapeutics, Llc,
Kentmere Veterinary Hospital,
Africa Centre For Scientific Discovery,
Gridpoint.
Sesh Incorporated's categories are Biotechnology Research
Sesh Incorporated's founding year is 2024
